Latest Financial Health News

Stelar Metals is actively negotiating new project acquisitions across critical minerals while implementing cost-cutting measures to safeguard its cash position of $2.3 million at the end of September 2025.

Ark Mines Ltd reported a significant cash burn in the September quarter, prompting a $500,000 capital raise and plans to secure $4 million from a royalty sale to sustain operations.

Associate Global Partners Limited reported a 4.6% increase in funds under management to $1.464 billion for Q3 2025, driven by robust inflows and standout returns from its WCM strategies. The company also sustained positive operating cash flows for the fourth consecutive quarter.

BlinkLab has completed its U.S. autism pilot study with strong diagnostic accuracy and expanded its pivotal FDA trial to seven leading research centers, positioning itself for regulatory submission in late 2026.

Mont Royal Resources has completed a transformative merger with Commerce Resources, securing A$10 million to advance the Ashram Rare Earths Project, positioning itself as a key player in North America’s critical minerals sector.

Tyranna Resources has advanced its exploration and acquisition efforts in Angola, securing a major stake in the Chinguar Gold Project and extending its lithium-caesium project tenure, supported by a solid cash position.

Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.

Alcoa Corporation reported a net income of $232 million for Q3 2025, driven by strategic asset sales and operational milestones including the permanent closure of its Kwinana alumina refinery and the sale of its Saudi Arabia joint venture stake.

Immutep Limited reports strong progress in its Phase III lung cancer trial with over 170 patients enrolled, alongside positive FDA feedback and a robust cash position supporting ongoing development.

Voltaic Strategic Resources has identified new gold mineralised corridors at Meekatharra and confirmed rare earth potential at Paddys Well, while maintaining a robust cash position of A$7.9 million.

Renergen Limited forecasts a significant rise in loss per share for H1 2025, driven by one-off transaction costs and full commissioning expenses. The company’s updated trading statement reveals losses could nearly double compared to last year.

Australasian Metals Limited advances exploration at its May Queen Gold Project with promising geophysical survey results and plans for a significant drilling campaign, while maintaining a robust financial footing.